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Abstract
Background: In 2010, WHO expanded previously-recommended indications for anti-retroviral treatment to include all HIV-
infected TB patients irrespective of CD4 count. India, however, still limits ART to those TB patients with CD4 counts ,350/
mm3 or with extrapulmonary TB manifestations. We sought to evaluate the additional number of patients that would be
initiated on ART if India adopted the current 2010 WHO ART guidelines for HIV-infected TB patients.
Methods: We evaluated all TB patients recorded in treatment registers of the Revised National TB Control Programme in
June 2010 in the high-HIV prevalence state of Karnataka, and cross-matched HIV-infected TB patients with ART programme
records.
Results: Of 6182 TB patients registered, HIV status was ascertained for 5761(93%) and 710(12%) were HIV-infected. 146(21%)
HIV-infected TB patients were on ART prior to TB diagnosis. Of the remaining 564, 497(88%) were assessed for ART eligibility;
of these, 436(88%) were eligible for ART according to 2006 WHO ART guidelines. Altogether, 487(69%) HIV-infected TB
patients received ART during TB treatment. About 80% started ART within 8 weeks of TB treatment and 95% received an
efavirenz based regimen.
Conclusion: In Karnataka, India, about nine out of ten HIV-infected TB patients were eligible for ART according to 2006 WHO
ART guidelines. The efficiency of HIV case finding, ART evaluation, and ART initiation was relatively high, with 78% of eligible
HIV-infected patients actually initiated on ART, and 80% within 8 weeks of diagnosis. ART could be extended to all HIV-
infected TB patients irrespective of CD4 count with relatively little additional burden on the national ART programme.
Citation: Kumar AMV, Gupta D, Rewari BB, Bachani D, Mohammed S, et al. (2011) Will Adoption of the 2010 WHO ART Guidelines for HIV-Infected TB Patients
Increase the Demand for ART Services in India? PLoS ONE 6(9): e24297. doi:10.1371/journal.pone.0024297
Editor: Robert J. Wilkinson, Institute of Infectious Diseases and Molecular Medicine, South Africa
Received June 8, 2011; Accepted August 4, 2011; Published September 8, 2011
Copyright:  2011 Kumar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported through an operational research course, which was jointly developed and run by the Centre for Operational Research,
International Union Against Tuberculosis and Lung Disease, and the Operational Research Unit, Medecins sans Frontieres, Brussels. The study itself was not
funded. However, the publication fees is being funded by Centre for Operational Research, International Union Against Tuberculosis and Lung Disease. The funder
had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: kumaramv@rntcp.org (AK); sathyasaakshi@gmail.com (S. Srinath)
Introduction
HIV-infected TB patients experience a high case-fatality rate
during anti-tuberculosis (TB) treatment[1]. Antiretroviral therapy
(ART) reduces this risk of death, provided ART is started early
enough during anti-TB treatment[2]. The efficient and timely
initiation of ART in HIV-infected TB patients is crucial to reduce
mortality among HIV-infected TB patients.
In India, the National AIDS Control Programme (NACP) ART
guidelines are still in line with 2006 World Health Organization
(WHO) Guidelines for ART[3,4]. As per 2006 guidelines, all HIV-
infected persons with extra pulmonary (EPTB) or disseminated TB
and HIV-infected pulmonary tuberculosis (PTB) patients with a
CD4-lymphocyte count #350/mm3 are considered eligible for
ART. In contrast, the 2010 WHO ART Guidelines recommend
that ART be initiated in all HIV-infected TB patients (PTB and
EPTB), irrespective of CD4 count, as soon as possible during the
initial phase of anti-TB treatment[5].
India proposes to change over to the new 2010 WHO ART
Guidelines, but there is concern that giving ART to all HIV-infected
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TB patients may have major resource implications for the national
ART programme. There is little information available about what
proportion of HIV-infected TB patients are eligible for ART
according to the current NACP criteria and how this might change
if the new 2010 WHO ART Guidelines were adopted and
implemented in India. There was some information on ART
eligibility from a previous study, but this was not representative as
most of the HIV-infected TB patients could not be evaluated for
ART eligibility because of poor information on CD4 counts [6].
Better knowledge of ART eligibility and the efficiency with which
patients are initiated on ART is critical for policy makers to plan for
increases in demand for drugs and services.
We conducted a cross-sectional survey in the state of
Karnataka, one of the highest HIV prevalent states in India, to
evaluate the additional number of patients that would be initiated
on ART if India adopted current WHO ART guidelines for
HIV-infected TB patients. The specific objectives were to assess:-
i) number (proportion) of TB patients ascertained for HIV status
with their results, ii) number (proportion) of HIV-infected TB
patients eligible for ART and started on ART during anti-TB
treatment and iii) when ART was started and the type of regimen
used.
Methods
Design
This was a cross sectional study involving review of routinely
collected data recorded in TB and HIV programme records.
Setting
Karnataka, a south Indian state with a population of 61
million, has an estimated 0.25 million people living with HIV in
2009 and accounts for about 10% of country’s HIV burden[7].
Hence, the state has been classified as ‘high priority’ for HIV
interventions by the Indian National AIDS Control Organiza-
tion (NACO) on the basis of consistently high HIV seroprev-
alence rates of .1% during sentinel surveillance at antenatal
clinics[8,9]. In the state, tuberculosis control programme
services are available through a decentralized network of
primary health care facilities which provide general health
services including diagnosis and treatment for TB. All TB
patients are treated with standardized fully intermittent thrice-
weekly short-course regimens (6-9 months) administered under
direct observation and are registered at one of the 125 sub-
district level TB programme management units according to
Indian programme guidelines[10].
There is a national policy of Provider-Initiated HIV Testing and
Counseling (PITC) of all TB patients, and HIV-infected TB
patients are provided cotrimoxazole preventive therapy (CPT) and
referred to ART centres for assessment of ART eligibility and
initiation on ART if found to be eligible[11]. TB patients are
referred for free HIV counseling and testing to one of the 1000
integrated counseling and testing centre (ICTC) throughout the
state, which are usually co-located with sputum microscopy
services. Free ART is provided through a network of 40 ART
centres (with at-least one ART centre in every district), where
HIV-infected patients (including TB patients) are screened for
ART eligibility and offered treatment and care. These service
delivery sites under NACP follow the national guidelines for
counseling, testing, care and treatment of HIV-infected pa-
tients[12]. In the year 2010, of 68,655 TB patients registered in
Karnataka, 82% were tested for HIV and 8,485 HIV-infected TB
patients were identified[13].
Study population
From a cohort of TB patients (except transfer-in cases)
registered in Karnataka state, India, between 1st and 30th June
2010, all those identified as HIV-infected were consecutively
included in the study.
Data collection and validation
Data on the number of TB patients registered, number with
known HIV status and number HIV-infected were extracted from
the TB registers. TB-HIV data were collected into a pre-tested
structured data abstraction form by trained consultants between
November and December 2010; data collected included age, sex,
type and category of TB, CD4 count, ART initiation, timing of
ART initiation and ART regimen. These data were collected from
the existing programme records of Revised National TB Control
Programme (TB registers and TB treatment cards) and NACP (TB/
HIV register, pre-ART registers, ART registers and the electronic
patient database maintained at the ART centres). If HIV-infected
TB patients were receiving ART from another district, the records
of the respective ART centres were reviewed. If there were
discrepancies between data in the different records, these were
resolved by interviewing the medical officers of the respective health
institution. Except where mentioned, standard definitions according
to the national programme guidelines were used.
Data entry and analysis
Data were double-entered into an EpiData database by two
data entry operators independently[14]. Databases were com-
pared and discrepancies resolved through referral to the original
questionnaire. Proportions of TB patients with known HIV status
and proportions of HIV-infected TB patients who were eligible for
ART, initiated on ART with timing of ART initiation were
calculated.
Ethics approval
Ethics approval was obtained by the Ethics Advisory Group of
the International Union against TB and lung disease (The Union).
Approvals of Central TB Division, Ministry of Health and Family
Welfare and National AIDS Control organization were also
obtained for conducting this evaluation.
Results
Of 6,182 TB patients registered in Karnataka in June 2010,
HIV status was known for 5,761 (93%), and 710 (12%) were
recorded as HIV-infected. The demographic, clinical and immu-
nological characteristics of HIV-infected TB patients are shown in
Table 1. Two thirds of the patients were men, with the majority
being in the age group 25–54 years. Most of the patients had new
TB and about three quarters of patients were classified as
pulmonary tuberculosis with almost equal division between
sputum-smear positive and sputum smear negative. CD4-counts
were recorded for 621 (87%) patients, of whom 512 (82%) had a
CD4 count less than or equal to 350 cells/mm3.
Assessment for ART eligibility and initiation of ART is shown
in Figure 1. Of all 710 HIV-infected TB patients identified, 146
(21%) were already on ART prior to TB diagnosis. Of the 564
patients who were not on ART at the time of TB diagnosis, 145
(25%) had extra-pulmonary TB and were immediately ART
eligible. Of the 419 pulmonary TB patients not already on ART,
352 (84%) had available CD4 information, among whom 291
(83%) had a CD4 count ,350 cells/mm3 and were ART eligible.
Altogether, 497/564 (88%) could be assessed for ART eligibility
and among them, 436 (88%) were eligible for ART.
HIV-TB & ART Eligibility in Karnataka, India
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Overall, 487(67%) HIV-infected TB patients received ART
during TB treatment, with ART started either before or after the
diagnosis of TB.
For those patients who received ART either before or after TB
diagnosis, the time of initiation of ART and the type of regimen
are shown in Table 2. Of the 341 patients who started ART after
TB diagnosis, 272 (80%) started within eight weeks of commenc-
ing anti-TB treatment. Almost 95% of patients received an
efavirenz-based ART regimen.
Discussion
This study in Karnataka state showed the majority of TB
patients in a high HIV prevalence state in India were tested for
HIV, and of those found to be HIV-positive nearly 90% were
eligible for ART according to current NACP and 2006 WHO
ART guidelines. As a public health approach to ART, this
strongly justifies the adoption of the WHO 2010 ART Guidelines,
recommending that all HIV-infected TB patients are started on
ART regardless of CD4 count. As ,10% of HIV-infected TB
patients had CD4 counts . 350 cells/mm3, the adoption of the
WHO ART Guideline recommendation for HIV-infected TB
patients is not likely to place a large additional burden on the
national ART programme.
We also determined sub-optimal programme efficiency in the
initiation of ART for patients eligible under current guidelines;
23% of HIV-infected TB patients should have got ART, but did
not. To illustrate this point, we can apply these findings to the state
of Karnataka. In the state of Karnataka in 2010, of 68,665
tuberculosis patients registered for treatment, 56,622 knew their
HIV status and 8,485 were identified as HIV-infected[13].
Assuming existing operational efficiency, 67% (5,685) would be
receiving ART and another 23% (1,951) would be eligible for
ART as per current ART eligibility criteria, but not yet on ART
due to operational challenges. Increasing the programme
efficiency of ART initiation could place 1,951 additional people
on ART. About 10% (849) would be eligible for ART if new
guidelines are implemented. Given that there were about 55,102
people alive and on ART in the state of Karnataka at the end of
2010, the annual addition of 849 (1.5%) people to the ART
programme from ‘changed guidelines’, and 1,951 (3.5%) people
from ‘improved programme efficiency’ would be modest. Im-
provements in programme efficiency of ART initiation for HIV-
infected TB patients offers another important opportunity to
improve ART coverage in HIV-infected TB patients, and in the
larger context of ART provision would pose little additional
burden on existing HIV treatment services.
This was the first state-wide study in India assessing the
management of HIV diagnosis and care in TB patients under
programmatic settings. The only other study to examine this issue
in India found similar results in 2 districts of South India, in which
about 83% of HIV-infected TB patients were eligible for ART; but
this finding suffered from very low completion of CD4 evaluation
in that cohort[6]. Similar findings have been reported from sub-
Saharan Africa, where 90% of HIV-infected TB patients had CD4
counts below 350 cells/mm3[15]. Our study covered the entire
state of Karnataka and had very high rates of HIV case finding
among TB patients and CD4 testing. Hence, these results are
likely to be broadly generalizable. Given the similarity of results
from various settings, we also believe that the results may be
extrapolated to other high HIV prevalent states in the country,
though more research is required to confirm this. The high rates of
HIV testing among TB patients in this cohort could be attributed
to the widespread availability of HIV testing services co-located
with the TB microscopy centres in the state. Since TB patients can
be a high-yield source of HIV case finding, this calls for scale-up of
co-located HIV testing and TB testing services across the country.
This study also emphasizes that in resource-poor settings, the
majority of HIV-infected TB patients who are not already on
ART present to health services late and with low CD4 counts. The
reasons for late presentation are many and include late diagnosis
of HIV and the low CD4 threshold currently used for initiating
ART among all HIV-infected persons. Hence, the national
programmes should explore other opportunities of improved and
earlier diagnosis of HIV-infected TB patients like PITC of TB
suspects and strengthening intensified TB case finding activities at
HIV care settings by the use of WHO-endorsed, new, rapid
molecular technologies to diagnose TB[16]. The 2010 WHO
Table 1. Characteristics of HIV-infected TB patients registered
in Karnataka state, India, in June 2010.
Category Sub-category Number (%)
All patients 710 (100)*
Sex Male 465 (66)
Female 245 (34)
Age group 0–14 years 33 (5)
15–24 years 23 (3)
25–35 years 214 (30)
35–44 years 283 (40)
45–54 years 114 (16)
55–64 years 38 (5)
$65 years 5 (1)
Type of TB** Pulmonary TB 516 (73)
Extra pulmonary TB 194 (27)
Smear status of Pulmonary TB
(N = 516)
Smear Positive 285 (55)
Smear Negative 216 (42)
Smear Unknown 15 (3)
Site of Extra pulmonary TB (N=194) Lymph Node 62 (32)
Pleura 39 (20)
Meninges/CNS 33 (17)
Abdomen 30 (16)
Other 7 (3)
Not recorded 23 (12)
TB registration type New 593 (83)
Relapse 30 (4)
Treatment after Default 19 (3)
Treatment after Failure 5 (1)
Other 63 (9)
CD4 cell count ,50/mm3 72 (10)
50–200/mm3 291 (41)
201–350/mm3 149 (21)
.350/mm3 109 (15)
Not available 89 (13)
*Percentages may not always add up to 100 due to rounding errors.
**There were 10 patients who had both pulmonary and extrapulmonary TB;
they have been classified under extrapulmonary TB as they belong to HIV stage
4 and are ART eligible.
TB-Tuberculosis; HIV-Human immunodeficiency virus; CNS-Central Nervous
System.
doi:10.1371/journal.pone.0024297.t001
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ART guidelines which recommends initiation of ART for all
PLHIV with CD4 count of #350/mm3 is a welcome change in
this regard which may not only prevent TB cases from occurring
but may also ensure that those who develop TB would have higher
CD4 counts and consequently the likelihood of better clinical
outcomes. NACP and RNTCP are considering all the above
options in their next joint national strategic plan (2012-17) to
achieve improved and earlier diagnosis of HIV-infected TB
patients[17].
This study also revealed operational weaknesses in ART
services. There were various reasons for poor ART uptake that
included failure to reach the ART centre, not getting CD4
counts done, having a CD4 count . 350 cells/uL in the case of
pulmonary tuberculosis and not returning to the ART centre after
Figure 1. Eligibility for and initiation of antiretroviral treatment in HIV-infected TB patients registered in Karnataka state, India, in
June 2010. *4 PTB patients were started on ART even though not eligible as per guidelines TB-Tuberculosis; HIV-Human immunodeficiency virus;
PTB-pulmonary tuberculosis; EPTB-extrapulmonary tuberculosis; NACO-National AIDS Control Organization; ART-antiretroviral treatment; ARTC-ART
centre.
doi:10.1371/journal.pone.0024297.g001
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starting TB treatment. Some of these patients may have died or
been too sick to reach the ART centre. Removal of the CD4 count
hurdle as part of ART eligibility criteria may make it easier to start
ART. More than one in five patients defined as ART eligible still
failed to receive ART during TB treatment. As per NACP
guidelines, patients were required to show proof of address and
needed to make 2–3 visits for baseline investigations and adherence
counseling before initiation of ART. Though this was important to
ensure long term adherence to treatment, it might have contributed
to losing track of even those who were eligible for ART. An
assessment of reasons for the lack of ART initiation for eligible
patients was beyond the scope of the current study and this needs
further investigation. On a positive note, the majority of patients
who started ART did so within 8 weeks of commencing TB
treatment in accordance with the NACP and WHO recommenda-
tions, with efavirenz-based ART regimens being those most
commonly used as per current NACP guidelines. Early ART
initiation for HIV-infected TB patients has been convincingly
shown to save lives, and the timeliness of ART initiation should be
monitored to ensure continued effective implementation.
This study had some limitations mainly related to our reliance
on data collected routinely by the national TB and HIV
programmes, where high accuracy of recording is difficult to
ensure. Although the 2010 WHO ART guidelines are justified as a
public health approach, it is important to study the TB treatment
outcomes among the subgroup of HIV-infected TB patients with
CD4 count of .350/mm3 and assess if they actually benefit by
early initiation of ART. A previous study from Cote d’Ivoire
indicated that although mortality was less among HIV-infected TB
patients with CD4 count of .200/mm3 when compared with
those whose CD4 count was ,200/mm3, it still remained many
times higher than in HIV-negative TB patients[18]. Information
on mortality in HIV-infected TB patients whose CD4 counts of
.350/mm3 is limited and this needs further study. Further, we did
not extend our research to do a costing exercise, but this can and
should be a subject of further analysis.
In conclusion, this study indicates that about 90% of HIV-
infected TB patients are eligible for ART as per 2006 WHO ART
guidelines. Hence as a public health approach, this strongly
justifies the adoption of 2010 WHO ART guidelines which
recommends that all HIV-infected TB patients should be initiated
on ART irrespective of CD4 count; this policy change should
have few additional resource implications for the national ART
programme. However, systematic measures need to be taken by
the national TB and HIV programmes to improve access of HIV-
infected TB patients to ART and bridge the gap in ART uptake.
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